Form 4 for FRPT Freshpet, Inc.
Accepted 2026-05-22 17:03:52 ET · period of report 2026-05-20 · accession 0000929638-26-001959 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $10.23 | +62.4K | 247.5K | +34% | +$638.0K |
| DT | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | S - Sale+OE | $47.92 | -42.9K | 204.6K | -17% | -$2.06M |
| DMTI | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $10.23 | +21.6K | 51.5K | +73% | +$221.3K |
| DMTI | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | S - Sale+OE | $47.52 | -4,675 | 49.7K | -9% | -$222.2K |
| DT | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $0.00 | -62.4K | 430.7K | -13% | $0 |
| DMTI | 2026-05-22 17:03 | 2026-05-20 | FRPT | Cyr William B. | CEO, Dir | M - OptEx | $0.00 | -21.6K | 55.1K | -28% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-20 | M | A | 62,369 | $10.23 | 247,492 | D | — | — | |
| 2 | Common | Common Stock | 2026-05-20 | S | D | 42,907 | $47.92 | 204,585 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 3 | Common | Common Stock | 2026-05-20 | M | A | 4,620 | $10.23 | 22,867 | I By Spouse | — | — | |
| 4 | Common | Common Stock | 2026-05-20 | S | D | 999 | $47.52 | 21,868 | I By Spouse | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 5 | Common | Common Stock | 2026-05-20 | M | A | 9,030 | $10.23 | 55,356 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | |
| 6 | Common | Common Stock | 2026-05-20 | S | D | 1,951 | $47.52 | 53,405 | I By Irrevocable Spousal Trust for Linda W. Cyr | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 7 | Common | Common Stock | 2026-05-20 | M | A | 7,981 | $10.23 | 51,458 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | |
| 8 | Common | Common Stock | 2026-05-20 | S | D | 1,725 | $47.52 | 49,733 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025. |
| 9 | Derivative | Options to purchase common stock | 2026-05-20 | M | D | 62,369 | $0.00 | 430,655 | D | $10.23 · — to 2026-09-06 | 62,369 Common Stock | (F2) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 10 | Derivative | Options to purchase common stock | 2026-05-20 | M | D | 4,620 | $0.00 | 31,900 | I By Spouse | $10.23 · — to 2026-09-06 | 4,620 Common Stock | (F2) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 11 | Derivative | Options to purchase common stock | 2026-05-20 | M | D | 9,030 | $0.00 | 62,350 | I By Irrevocable Spousal Trust for Linda W. Cyr | $10.23 · — to 2026-09-06 | 9,030 Common Stock | (F2) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |
| 12 | Derivative | Options to purchase common stock | 2026-05-20 | M | D | 7,981 | $0.00 | 55,095 | I By Linda W. Cyr 2020 Irrevocable Trust for Descendants | $10.23 · — to 2026-09-06 | 7,981 Common Stock | (F2) The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020. |